These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2127603)

  • 21. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian stimulation with gonadotropin-releasing hormone (GnRH) analogue improves the in vitro fertilization (IVF) pregnancy rate with both transvaginal and laparoscopic oocyte recovery.
    Dor J; Ben-Shlomo I; Lipitz S; Levran D; Etchin A; Rudak E; Mashiach S
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):351-4. PubMed ID: 2150203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of short and long ovulation induction protocols used in ART applications according to the ovarian response and outcome of pregnancy.
    Tavmergen E; Göker EN; Sendag F; Sendag H; Levi R
    Arch Gynecol Obstet; 2002 Jan; 266(1):5-11. PubMed ID: 11998967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of different ovarian stimulation protocols for in vitro fertilization.
    Pados G; Tarlatzis BC; Bontis J; Lagos S; Papadimas J; Spanos E; Mantalenakis S
    Gynecol Endocrinol; 1995 Jun; 9(2):103-12. PubMed ID: 7502685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.
    Padilla SL; Dugan K; Maruschak V; Shalika S; Smith RD
    Fertil Steril; 1996 Apr; 65(4):796-9. PubMed ID: 8654641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of clomiphene citrate and leuprolide acetate on luteal-phase hyperprolactinemia during ovarian stimulation with menopausal gonadotropins.
    Kaplan CR; Koong MK; Olive DL; Riehl RM; Burns WN; Groff TR; Schenken RS
    J In Vitro Fert Embryo Transf; 1991 Dec; 8(6):308-13. PubMed ID: 1770270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination clomiphene citrate/human menopausal gonadotropin stimulation protocols for in vitro fertilization-embryo transfer.
    Hill GA; Diamond MP; Maxson WS; Herbert CM; Webster BW; Vaughn WK; Osteen KG; Rogers BJ; Wentz AC
    J In Vitro Fert Embryo Transf; 1987 Feb; 4(1):34-9. PubMed ID: 3108425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian response in repetitive cycles induced by menotrophin alone or combined with gonadotrophin releasing hormone analogue.
    Ron-El R; Raziel A; Herman A; Golan A; Nahum H; Soffer Y; Caspi E
    Hum Reprod; 1990 May; 5(4):427-30. PubMed ID: 2141846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GnRH agonist increases pregnancy potential of retrieved oocytes given adequate preincubation before insemination: a comparative study.
    Feldberg D; Goldman GA; Dicker D; Ashkenazi J; Shelef M; Goldman JA
    Eur J Obstet Gynecol Reprod Biol; 1991 Apr; 39(2):111-6. PubMed ID: 1828775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel strategy of using corifollitropin alfa in the ultrashort gonadotropin-releasing hormone agonist (GnRHa) protocol in unselected patients: A patient-friendly alternative.
    Yu TN; Liu YL; Wang PH; Chen CH; Chen CH; Tzeng CR
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):656-661. PubMed ID: 31542088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro fertilization-embryo transfer.
    Hill GA; Freeman M; Bastias MC; Rogers BJ; Herbert CM; Osteen KG; Wentz AC
    Fertil Steril; 1989 Nov; 52(5):801-6. PubMed ID: 2509252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study.
    Lavy G; Pellicer A; Diamond MP; DeCherney AH
    Fertil Steril; 1988 Jul; 50(1):74-8. PubMed ID: 3133250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval.
    Meldrum DR; Wisot A; Hamilton F; Gutlay AL; Kempton WF; Huynh D
    Fertil Steril; 1989 Mar; 51(3):455-9. PubMed ID: 2493403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of steroid and protein hormones in antral fluids of women treated with different combinations of gonadotropins, clomiphene citrate, and a gonadotropin-releasing hormone analog.
    Stone BA; Vargyas JM; Marrs RP; Quinn PJ; Batzofin JH; Tan T; Kerin JF; Serafini PC
    Fertil Steril; 1988 Feb; 49(2):249-57. PubMed ID: 3123276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with a new fixed-stimulation protocol without hormone determinations for programmed oocyte retrieval for in-vitro fertilization.
    Kemeter P; Feichtinger W
    Hum Reprod; 1989 Nov; 4(8 Suppl):53-8. PubMed ID: 2515212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Van Wely M; Westergaard LG; Bossuyt PM; Van der Veen F
    Cochrane Database Syst Rev; 2003; (1):CD003973. PubMed ID: 12535497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG.
    Van der Elst J; Van den Abbeel E; Camus M; Smitz J; Devroey P; Van Steirteghem A
    Hum Reprod; 1996 Oct; 11(10):2097-106. PubMed ID: 8943509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.